PLCG2 variants in cherubism
- 27 August 2024
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 154 (6) , 1554-1558
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (Z01-AR041198)
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R24 AI 17745)
This publication has 13 references indexed in Scilit:
- PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variantsJournal of Allergy and Clinical Immunology, 2023
- Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiencyJournal of Allergy and Clinical Immunology, 2023
- SH3BP2-related fibro-osseous disorders of the maxilla and mandible: A systematic reviewInternational Journal of Oral and Maxillofacial Surgery, 2022
- Expanding the clinical features of autoinflammation and phospholipase Cγ2‐associated antibody deficiency and immune dysregulation by description of a novel patientJournal of the European Academy of Dermatology and Venereology, 2019
- A Hypermorphic Missense Mutation in PLCG2 , Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with ImmunodeficiencyThe American Journal of Human Genetics, 2012
- Cold Urticaria, Immunodeficiency, and Autoimmunity Related toPLCG2DeletionsNew England Journal of Medicine, 2012
- Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubismGenes to Cells, 2011
- SH3BP2 mutations potentiate osteoclastogenesis via PLCγJournal of Orthopaedic Research, 2010
- Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubismNature Genetics, 2001
- Cherubism: clinicopathologic featuresSkeletal Radiology, 1999